Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

15 trials with published results (27%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.5%

3 terminated out of 55 trials

Success Rate

93.8%

+7.3% vs benchmark

Late-Stage Pipeline

20%

11 trials in Phase 3/4

Results Transparency

33%

15 of 45 completed with results

Key Signals

15 with results94% success

Data Visualizations

Phase Distribution

35Total
Not Applicable (13)
P 1 (4)
P 2 (7)
P 3 (5)
P 4 (6)

Trial Status

Completed45
Unknown6
Terminated3
Withdrawn1

Trial Success Rate

93.8%

Benchmark: 86.5%

Based on 45 completed trials

Clinical Trials (55)

Showing 20 of 20 trials
NCT02345655Not ApplicableCompletedPrimary

On-site Evaluation of Substances Consumption on Opiate Maintenance

NCT02867124Phase 3CompletedPrimary

Long-acting Naltrexone for Pre-release Prisoners

NCT03150173Phase 2CompletedPrimary

Onsite Buprenorphine Treatment at Syringe Exchange Programs

NCT02751762Completed

A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Opioids for the Treatment of Chronic Pain

NCT03831113Phase 2TerminatedPrimary

Pharmacologically-based Strategies for Opioid Substitution Therapy During Pregnancy

NCT02863601CompletedPrimary

Impact of Pregnancy on Buprenorphine Pharmacokinetics and Pharmacodynamics

NCT02396979Phase 4Completed

Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia

NCT02674711Not ApplicableCompleted

Study of Opioid Use After Lumbar and Cervical Spine Surgery

NCT02539823Phase 2CompletedPrimary

Acute and Short-term Effects of CBD on Cue-induced Craving in Drug-abstinent Heroin-dependent Humans

NCT00929253Not ApplicableCompletedPrimary

Efficacy of Computer Delivered Community Reinforcement Approach (CRA) (Bup II)

NCT02252068Not ApplicableCompleted

Study of Treatment for Opioid Dependence and Anxiety Disorders

NCT01605539Phase 2CompletedPrimary

Acute and Short-term Effects of Cannabidiol Admin on Cue-induced Craving in Drug-abstinent Heroin Dependent Humans

NCT02660619Completed

Validation of PRISM-5-Op, Measure Of Addiction To Prescription Opioid Medication

NCT03583138Completed

HIV, Buprenorphine, and the Criminal Justice System (STRIDE2)

NCT01550341Not ApplicableCompleted

HIV, Buprenorphine, and the Criminal Justice System

NCT02667158Completed

A Survey to Eval the Relation Between Doctor/Pharmacy Shopping and Outcomes Suggestive of Misuse, Abuse and/or Diversion

NCT02667210Completed

Study to Eval Relation Btw Doctor/Pharmacy Shopping & Outcomes of Misuse, Diversion, Abuse, Addiction by Med Rec Review

NCT02668549Completed

Cross-Sectional Study to Define and Validate "Doctor/Pharmacy Shopping" as Outcomes Suggestive of Abuse and/or Addiction

NCT02678507Completed

A Quantitative Study to Assess the Construct Validity of the Prescription Opioid Misuse and Abuse Questionnaire

NCT02660606Completed

A Qualitative Study to Assess the Content Validity of the Prescription Opioid Misuse and Abuse Questionnaire

Scroll to load more

Research Network

Activity Timeline